TCI Wealth Advisors’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-27
Closed -$188 1532
2023
Q1
$188 Hold
27
﹤0.01% 2345
2022
Q4
$278 Hold
27
﹤0.01% 2290
2022
Q3
$0 Hold
27
﹤0.01% 2484
2022
Q2
$1K Hold
27
﹤0.01% 2171
2022
Q1
$2K Sell
27
-262
-91% -$23.4K ﹤0.01% 2005
2021
Q4
$41K Buy
289
+155
+116% +$26.6K 0.01% 454
2021
Q3
$28K Buy
134
+66
+97% +$14.5K ﹤0.01% 561
2021
Q2
$14K Buy
68
+10
+17% +$1.83K ﹤0.01% 753
2021
Q1
$11K Buy
+58
New +$11.6K ﹤0.01% 816
2019
Q2
Sell
-35
Closed 1510
2019
Q1
$0 Buy
35
+15
+75% +$474 ﹤0.01% 1495
2018
Q4
$1K Buy
20
+10
+100% +$388 ﹤0.01% 1268
2018
Q3
$0 Hold
10
﹤0.01% 1536
2018
Q2
$0 Hold
10
﹤0.01% 1570
2018
Q1
$0 Buy
+10
New +$402 ﹤0.01% 1407
2017
Q4
Sell
-15
Closed 1404
2017
Q3
$0 Sell
15
-10
-40% -$224 ﹤0.01% 1364
2017
Q2
$1K Buy
25
+15
+150% +$294 ﹤0.01% 1181
2017
Q1
$0 Hold
10
﹤0.01% 1355
2016
Q4
$0 Hold
10
﹤0.01% 1427
2016
Q3
$0 Buy
+10
New +$1.29K ﹤0.01% 1391
2015
Q3
Sell
-100
Closed -$22K 1002
2015
Q2
$22K Buy
+100
New +$17.6K 0.01% 385

Other funds holding NVAX

TCI Wealth Advisors's NVAX Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Novavax (NVAX) in Q2 2023, closing a stake of 27 shares — an estimated $188 sold.

TCI Wealth Advisors first reported a position in NVAX in Q2 2015 and held it in 20 quarters. The position peaked at $41K in Q4 2021. 215 funds tracked by Wall St. Rank hold NVAX as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Novavax position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 27 Novavax shares in Q2 2023, an estimated $188.
  • TCI Wealth Advisors first reported a position in Novavax in Q2 2015 and held it in 20 quarters.
  • TCI Wealth Advisors's Novavax position peaked at $41K in Q4 2021.
  • 215 funds tracked by Wall St. Rank held Novavax as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.